Virtual Biology's Reality Check

<p>Biohub&#39;s Virtual Biology Initiative just expanded to $1.8 billion — backed by the DOE, NIH, Google DeepMind, Isomorphic Labs, and Meta — to build the data foundations for predictive AI in biology. But a new perspective argues the field is celebrating too early: today&#39;s biological data are sparse across the spatial, temporal, and causal dimensions that actually determine how cells respond to drugs. This episode walks through why virtual cells are not digital twins, where the models could genuinely accelerate drug discovery first, and the validation ladder that separates credible prediction from hype. Produced by Dr. Jake Chen.</p>